Cargando…
The Effectiveness of Cinacalcet as an Adjunctive Therapy for Hereditary 1,25 Dihydroxyvitamin D(3)-Resistant Rickets
High doses of oral calcium or long-term calcium infusions are recommended to correct the hypocalcemia and secondary hyperparathyroidism in patients with hereditary 1,25 dihydroxyvitamin D(3)-resistant rickets (HVDRR). Preliminary studies revealed that calcimimetics may be a safe and effective therap...
Autores principales: | Akıncı, Ayşehan, Dündar, İsmail, Kıvılcım, Meltem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463292/ https://www.ncbi.nlm.nih.gov/pubmed/27796266 http://dx.doi.org/10.4274/jcrpe.3486 |
Ejemplares similares
-
Familial vitamin D resistant rickets: End-organ resistance to 1,25-dihydroxyvitamin D
por: Choudhury, Sangita, et al.
Publicado: (2013) -
Hereditary 1,25-dihydroxyvitamin D-resistant rickets (HVDRR) caused by a VDR mutation: A novel mechanism of dominant inheritance
por: Isojima, Tsuyoshi, et al.
Publicado: (2015) -
SAT257 Efficacy Of Oral Cinacalcet In Non-PTH Non-Malignant Hypercalcemia From Excess 1,25 Dihydroxyvitamin D
por: Mohan, Sneha, et al.
Publicado: (2023) -
Vitamin D-Resistant Rickets and Cinacalcet—One More Favorable Experience
por: Nicolescu, Ramona C., et al.
Publicado: (2018) -
THU233 Reduction Of Overutilization Of 1,25-Dihydroxyvitamin D
por: Brown, Jeremy, et al.
Publicado: (2023)